How much does a box of the Indian version of Ripretinib cost?

Ripretinib (Ripretinib) is an oral switch-controlled tyrosine kinase inhibitor. It is approved for the treatment of advanced gastrointestinal stromal tumor GIST after receiving three or more TKIs (including imatinib). Currently, there is no Indian version of Ripretinib produced and marketed overseas. Ripetinib original drug, specification50mg*30 tablets, which is marketed in China and has entered the ranks of medical insurance, may cost around 30,000 yuan per box. The expensive price may increase the pressure on families with heavy financial burdens. The US version of Ripetinib Specifications50mg*90 tablets sold overseas may be priced around RMB 77,000 per box (the price may fluctuate due to exchange rates). The pharmaceutical ingredients of foreign original drugs are basically the same as those of domestic original drugs.